Add office photos
Employer?
Claim Account for FREE
Glenmark Pharmaceuticals
3.8
based on 3.2k Reviews
Company Overview
Company Locations
Working at Glenmark Pharmaceuticals
Company Summary
Glenmark Pharma is discovering advance therapies for a new world. Ceating centers of excellence in dermatology, oncology, etc
Overall Rating
3.8/5
based on 3.2k reviews
3% below
industry average
Critically rated for
Promotions
Work Policy
Work from office
78% employees reported
Monday to Saturday
63% employees reported
Flexible timing
62% employees reported
Within city
37% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
223 employees reported
Health insurance
199 employees reported
Office cab/shuttle
154 employees reported
Cafeteria
55 employees reported
View all benefits
About Glenmark Pharmaceuticals
Founded in1977 (48 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersMumbai, Maharashtra, India
Office Locations
--
Websiteglenmarkpharma.com
Primary Industry
Other Industries
--
Are you managing Glenmark Pharmaceuticals's employer brand? To edit company information,
claim this page for free
Glenmark is a leading global innovative pharmaceutical company committed to enriching lives worldwide. Our vision is to discover possibilities and make lives of patients better across the globe by developing cures for unmet medical needs. We have a rich pipeline of innovative molecules in various phases of development which are targeted in areas of oncology, respiratory and dermatology.
Report error
Managing your company's employer brand?
Claim this Company Page for FREE
Glenmark Pharmaceuticals Ratings
based on 3.2k reviews
Overall Rating
3.8/5
How AmbitionBox ratings work?
5
1.5k
4
876
3
437
2
157
1
245
Category Ratings
3.7
Salary
3.7
Skill development
3.6
Company culture
3.6
Job security
3.5
Work-life balance
3.5
Work satisfaction
3.2
Promotions
Glenmark Pharmaceuticals is rated 3.8 out of 5 stars on AmbitionBox, based on 3.2k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Glenmark Pharmaceuticals
based on 3.1k reviews
3.8
Rated by 231 Women
Rated 3.7 for Job security and 3.6 for Work-life balance
3.8
Rated by 2.8k Men
Rated 3.7 for Salary and 3.7 for Skill development
Work Policy at Glenmark Pharmaceuticals
based on 409 reviews in last 6 months
Work from office
78%
Hybrid
18%
Permanent work from home
4%
Glenmark Pharmaceuticals Reviews
Top mentions in Glenmark Pharmaceuticals Reviews
+ 5 more
Compare Glenmark Pharmaceuticals with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 3.8/5 based on 3.2k reviews | 4.0/5 based on 7.4k reviews | 4.1/5 based on 6.6k reviews | 4.1/5 based on 7.5k reviews |
Highly Rated for |  No highly rated category | Skill development Work-life balance Salary | Skill development Company culture Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | Promotions | Promotions |  No critically rated category | No critically rated category |
Primary Work Policy | Work from office 78% employees reported | Work from office 73% employees reported | Work from office 82% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 3.8 Good rated by 231 women | 3.9 Good rated by 846 women | 4.0 Good rated by 409 women | 4.0 Good rated by 764 women |
Rating by Men Employees | 3.8 Good rated by 2.8k men | 4.0 Good rated by 6.2k men | 4.1 Good rated by 5.9k men | 4.1 Good rated by 6.4k men |
Job security | 3.6 Good | 3.5 Good | 3.7 Good | 3.7 Good |
View more
Glenmark Pharmaceuticals Salaries
Glenmark Pharmaceuticals salaries have received with an average score of 3.7 out of 5 by 3.2k employees.
Senior Officer
(960 salaries)
Unlock
₹3.1 L/yr - ₹8.1 L/yr
Officer
(829 salaries)
Unlock
₹2.4 L/yr - ₹6.9 L/yr
Junior Officer
(349 salaries)
Unlock
₹2.2 L/yr - ₹5.9 L/yr
Research Officer
(275 salaries)
Unlock
₹5 L/yr - ₹10.8 L/yr
Research Associate
(268 salaries)
Unlock
₹3.5 L/yr - ₹7.5 L/yr
Field Sales Officer
(266 salaries)
Unlock
₹2.4 L/yr - ₹6.5 L/yr
District Sales Manager
(249 salaries)
Unlock
₹4.8 L/yr - ₹11.1 L/yr
Production Officer
(225 salaries)
Unlock
₹1.9 L/yr - ₹6 L/yr
Medical Representative
(215 salaries)
Unlock
₹2.5 L/yr - ₹5.8 L/yr
Senior Research Officer
(178 salaries)
Unlock
₹9.1 L/yr - ₹15 L/yr
Glenmark Pharmaceuticals Interview Questions
Glenmark Pharmaceuticals Jobs
Popular Designations Glenmark Pharmaceuticals Hires for
Popular Skills Glenmark Pharmaceuticals Hires for
Current Openings
Glenmark Pharmaceuticals News
View all
Why VIP Industries, Glenmark, HFCL, RITES, Wheels India, 10 others will make waves in today’s trade (July 14)
- Glenmark Pharmaceuticals hit with US FDA warning letter for Indore facility.
- Neogen Chemical to raise ₹200 crore via issuance of NCDs.
- Titagarh Rail Systems acquires land for Vande Bharat coaches production.
HinduBusinessLine | 14 Jul, 2025
Stock Recommendations Today: TCS, HUL, Bharat Forge, Glenmark Pharma On Brokerages' Radar
- TCS, HUL, Bharat Forge, and Glenmark Pharma were top picks on brokerages' radar.
- UBS downgraded Bharat Forge and Maruti Suzuki while covering IDFC First Bank.
- Analyst views on TCS, leadership change at HUL, and brokerages' calls highlighted.
- Glenmark Pharma received mixed reviews from Nomura, HSBC, and Axis Capital.
- Brokerages shared insights on HUL's new CEO and TCS Q1 results, among others.
Bloomberg Quint | 11 Jul, 2025
Five Stocks To Buy Today: SBI, Prestige, Paytm, Container Corp. Among Others
- Stocks recommended for buying today include SBI, Prestige Estate Projects Ltd., Paytm's operator One97 Communications, Container Corp. of India, and Glenmark Pharmaceuticals Ltd.
- Experts like Nilesh Jain, Aditya Agarwala, Shrikant Chouhan, and Ajit Mishra provided their 'buy' recommendations on these stocks based on market data.
- Specific recommendations include buying Concor, One97 Communications, Prestige Estate Projects, SBI, and Glenmark at their current market prices with respective stop loss and target prices.
- It's important to note that the views expressed are of the individual experts, and viewers are advised to consult with their own financial advisors before making investment decisions.
Bloomberg Quint | 11 Jul, 2025
Why these 4 large-cap stocks HUL, TCS, JSW Infra, Glenmark Pharma will be in focus in today’s trade
- Tata Consultancy Services reported a 6% rise in net profit in the first quarter of FY26 but lower-than-expected revenue due to subdued discretionary spending and global uncertainties affecting demand.
- JSW Infrastructure's Resolution Plan for NCR Rail Infrastructure Limited, owning a Private Freight Terminal in Khurja, Uttar Pradesh, has been approved by the Committee of Creditors, receiving a Letter of Intent on July 10.
- Glenmark Pharmaceutical's subsidiary Ichnos Glenmark Innovation Inc signed a $700 million licensing deal with AbbVie for its lead drug candidate ISB 2001, showing promising outcomes in patients with relapsed / refractory multiple myeloma.
- The developments involving HUL, TCS, JSW Infra, and Glenmark Pharma are expected to be significant in today’s trade due to the respective updates in their operations and partnerships.
HinduBusinessLine | 11 Jul, 2025
Bandu’s Blockbusters for June 15, 2025
- Bandu, a young investor, picks five stocks weekly that he believes will perform well in the coming week.
- Readers are invited to guess which stock will give the best return by the following Friday (BSE prices).
- Submissions with the predicted stock and price rise should be emailed to bandublockbuster@gmail.com by Wednesday noon.
- The selected winner will receive a prize of ₹2,000.
- Bandu's stock picks for this week are Narayana Hrudayalaya, Biocon, Max Healthcare Institute, Glenmark Pharmaceuticals, and Supreme Petrochem.
- The previous week's winner was Hina Bheda, with the winning stock being Laurus Labs.
- Laurus Labs saw a return of 3.92% from a closing price of ₹641.80 on Jun 6 to ₹666.95 on Jun 13.
- Published on June 14, 2025.
HinduBusinessLine | 14 Jun, 2025
Glenmark Pharma To Launch Cancer Treatment Drug Zanubrutinib After DGCA Approval
- Glenmark Pharmaceuticals will launch cancer treatment drug zanubrutinib in India under the brand name Brukinsa.
- Zanubrutinib is the first Bruton’s tyrosine kinase inhibitor approved in India for treating five distinct B-cell malignancies.
- The drug is approved for chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom macroglobulinemia, mantle cell lymphoma, marginal zone lymphoma, and follicular lymphoma.
- The launch of Brukinsa marks a significant milestone in Glenmark's innovative oncology portfolio, providing Indian patients access to an established therapy with proven efficacy and safety.
Bloomberg Quint | 9 Jun, 2025
Glenmark Pharmaceuticals poised to launch Zanubrutinib in India
- Glenmark Pharmaceuticals is set to launch Zanubrutinib in India under the name Brukinsa, developed by BeiGene (now BeOne Medicines).
- Brukinsa is the first Bruton’s tyrosine kinase (BTK) inhibitor approved in India for treating five distinct B-cell malignancies.
- The introduction of Brukinsa aims to address the burden of difficult-to-treat haematological malignancies in India.
- The product, approved in over 70 countries, is part of efforts to expand patient access to innovative oncology treatments in the Asia Pacific region.
HinduBusinessLine | 9 Jun, 2025
Which Stocks To Buy Today? Gaurav Sharma Recommends Glenmark, Oberoi Realty
- Gaurav Sharma, an associate VP at Globe Capital, recommends buying Glenmark Pharmaceuticals Ltd., Oberoi Realty Ltd., and Indian Bank Ltd. stocks.
- For Glenmark Pharmaceuticals, Sharma suggests buying at Rs 1,512 with a stop-loss at Rs 1,470 and a target price of Rs 1,600.
- Oberoi Realty Ltd. is advised as a 'buy' at Rs 1,794 with a stop-loss at Rs 1,720 and a target price of Rs 1,945.
- Indian Bank is recommended for purchase at Rs 632 with a stop-loss at Rs 618 and a target price of Rs 665.
Bloomberg Quint | 4 Jun, 2025
A ‘test case’ unfolds over Novo Nordisk’s weight loss and diabetes drug semaglutide
- Novo Nordisk is in a patent infringement battle with Dr Reddy's Laboratories and OneSource Specialty Pharma over the weight loss and diabetes drug semaglutide.
- Last week, Dr Reddy's Laboratories stated in Delhi High Court that they won't sell the product in India without a local license, though they have a license to manufacture and export to countries without a Novo patent.
- This legal case is considered a 'test case' for drugmakers aiming to enter the semaglutide market, with implications for companies like Cipla, Lupin, and Glenmark who intend to produce the drug in India.
- Semaglutide patents will expire in Canada next January and in India a few months later, raising questions about export destinations and legal implications for infringement under different countries' laws.
HinduBusinessLine | 2 Jun, 2025
Novo Nordisk diabetes / weightloss drug semaglutide locked in a legal tangle with DRL
- Novo Nordisk's drug semaglutide, also known as Ozempic / Wegovy, faces a legal dispute with Dr Reddy’s Laboratories (DRL) in India over patent infringement.
- DRL informed the Delhi High Court that they do not have a license to sell the drug in India and will not do so until they obtain one.
- Indian drugmakers like Cipla, Lupin, and Glenmark are eyeing the opportunity presented when some semaglutide patents expire next year.
- Novo Nordisk and DRL are engaged in a legal battle over the export of the drug to countries where Novo Nordisk does not hold a patent, with the case scheduled for August 19.
HinduBusinessLine | 31 May, 2025
Powered by
Compare Glenmark Pharmaceuticals with
Zydus Lifesciences
4.0
Sun Pharmaceutical Industries
4.0
Aurobindo Pharma
4.0
Intas Pharmaceuticals
4.1
Hetero
3.9
Macleods Pharmaceuticals
3.6
Viatris
4.2
Alembic Pharmaceuticals
4.0
Abbott
4.1
Ipca Laboratories
3.9
Alkem Laboratories
3.9
Mankind Pharma
3.9
Torrent Pharmaceuticals
3.9
MSN Laboratories
3.6
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.3
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
3.9
DIVI'S Laboratories
3.6
Wockhardt
3.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Glenmark Pharmaceuticals
Cipla
Manufacturing, Pharma
4.1
• 7.5k reviews
Dr. Reddy's
Clinical Research, Pharma
4.0
• 7.4k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.1
• 6.6k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.0
• 6.5k reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 6.5k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 5.2k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.8k reviews
Hetero
Healthcare / Pharma, Clinical Research, Healthcare, Pharma
3.9
• 3.7k reviews
Macleods Pharmaceuticals
Biotech & Life sciences, Pharma
3.6
• 3.7k reviews
Viatris
Manufacturing, Pharma
4.2
• 3.4k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.4k reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.3k reviews
Glenmark Pharmaceuticals FAQs
When was Glenmark Pharmaceuticals founded?
Glenmark Pharmaceuticals was founded in 1977. The company has been operating for 48 years primarily in the Pharma sector.
Where is the Glenmark Pharmaceuticals headquarters located?
Glenmark Pharmaceuticals is headquartered in Mumbai, Maharashtra.
How many employees does Glenmark Pharmaceuticals have in India?
Glenmark Pharmaceuticals currently has more than 12,000+ employees in India. Marketing & Communication department appears to have the highest employee count in Glenmark Pharmaceuticals based on the number of reviews submitted on AmbitionBox.
Does Glenmark Pharmaceuticals have good work-life balance?
Glenmark Pharmaceuticals has a Work-Life Balance Rating of 3.5 out of 5 based on 3,100+ employee reviews on AmbitionBox. 74% employees rated Glenmark Pharmaceuticals 4 or above, while 26% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Glenmark Pharmaceuticals work-life balance reviews for more details.
Is Glenmark Pharmaceuticals good for career growth?
Career growth at Glenmark Pharmaceuticals is rated as moderate, with a promotions and appraisal rating of 3.2. 26% employees rated Glenmark Pharmaceuticals 3 or below, while 74% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Glenmark Pharmaceuticals promotions / appraisals reviews for more detailed insights.
What are the cons of working in Glenmark Pharmaceuticals?
Working at Glenmark Pharmaceuticals does have some drawbacks that potential employees should consider. The company is poorly rated for promotions / appraisal, work satisfaction and work life balance, based on 3,100+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
